Ucb Biopharma Srl

This study tests a drug called rozanolixizumab in 40 Chinese adults with generalized myasthenia gravis, a condition that causes muscle weakness. The main goal is to see if the drug improves daily activities over 43 days. Participants receive the drug and are monitored for safety …

This study is testing a drug called zilucoplan in children aged 2 to 17 who have generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug works in the body, if it is safe, and if it helps control symptoms. Only 8 children will take p…

This study tests a drug called rozanolixizumab in 12 children aged 2 to 17 with moderate to severe generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if the drug is safe and tolerable. Participants receive the drug as a shot under the skin,…

This study tests a drug called bimekizumab in teenagers (ages 9 to 17) with moderate to severe hidradenitis suppurativa, a painful skin condition that causes boils. The goal is to see how the drug works in the body and if it is safe. About 40 participants will receive the drug as…

This study looks at how much of the drug bimekizumab (Bimzelx) passes into the breast milk of mothers who are already taking it for conditions like psoriasis or arthritis. About 20 breastfeeding women will provide milk samples over several weeks. The goal is to understand possibl…